ABM Industries Inc: Form 10-Q for the period ended Jul 31, 2023
Filed with the SEC on Sep 7, 2023 and accepted by EDGAR at Sep 7, 2023, 11:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-05-01 to 2023-07-31 | $2.03bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-11-01 to 2023-07-31 | $6.00bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-05-01 to 2023-07-31 | $1.77bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-11-01 to 2023-07-31 | $5.23bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2023-05-01 to 2023-07-31 | $104.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-11-01 to 2023-07-31 | $411.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-05-01 to 2023-07-31 | $138.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-11-01 to 2023-07-31 | $303.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-05-01 to 2023-07-31 | $20.9m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-11-01 to 2023-07-31 | $61.8m | us-gaap:InterestExpense |
| Income tax | 3 months2023-05-01 to 2023-07-31 | $21.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-11-01 to 2023-07-31 | $55.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-05-01 to 2023-07-31 | $98.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-11-01 to 2023-07-31 | $188.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-05-01 to 2023-07-31 | $1.47 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-11-01 to 2023-07-31 | $2.83 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-05-01 to 2023-07-31 | $1.48 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-11-01 to 2023-07-31 | $2.84 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-05-01 to 2023-07-31 | 66,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-11-01 to 2023-07-31 | 66,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-11-01 to 2023-07-31 | $104.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-11-01 to 2023-07-31 | $34.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2022-11-01 to 2023-07-31 | $43.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2022-11-01 to 2023-07-31 | $27.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-07-31 | $97.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-31 | $1.73bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-31 | $4.97bn | us-gaap:Assets |
| Current liabilities | At period end2023-07-31 | $1.18bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-31 | $3.11bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-07-31 | $1.29bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-07-31 | $31.5m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2023-07-31 | $1.86bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000771497-23-000020. Last ingested by Listed: Nov 4, 2026, 11:52 ET. Listed shows no prices and gives no investment advice.